NCT03375437View on ClinicalTrials.gov

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

NAActive, not recruitingINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2025

Conditions
Soft Tissue SarcomaAdvanced CancerMetastatic Cancer
Interventions
GENETIC

Blood and tumor samples

"FFPE tumor block (archival or a dedicated freshly collected tumor biopsy) will be collected for all enrolled patients and centralized.~Blood sampling for Translational Research (optional) (2\*10mL EDTA)"

Trial Locations (10)

21079

Centre Georges-Francois Leclerc, Dijon

59000

Centre Oscar Lambret, Lille

63011

Centre Jean Perrin, Clermont-Ferrand

69008

Centre Léon Bérard, Lyon

Unknown

CHU de Limoges Hôpital Dupuytren, Limoges

Centre Antoine Lacassagne, Nice

Institut Gustave ROUSSY, Paris

Centre Eugène Marquis, Rennes

Institut de Cancérologie de la Loire Lucien Neuwirth, Saint-Priest-en-Jarez

54511 cedex

Institut de Cancérologie de Lorraine, Nancy

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Centre Leon Berard

OTHER

NCT03375437 - RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. | Biotech Hunter | Biotech Hunter